'Dartmouth medical school' presentation slideshows

Intracellular Pathogens

1.15k views • 83 slides

Margie Barber, MAc , CPA Chief Administrative Officer Arizona Cancer Center

505 views • 39 slides

Questions Policy Makers Are Failing to Ask About Healthcare Costs

Questions Policy Makers Are Failing to Ask About Healthcare Costs . Health Policy Seminar on Sunday, April 19 th , 2009 Washington, D.C. Shannon Brownlee Visiting Scholar, NIH Clinical Center Dept. of Bioethics Schwartz Senior Fellow, New America Foundation

503 views • 38 slides

Supporting Health Care Transitions from

546 views • 36 slides

Reimbursement and incentive contracts in health care

472 views • 34 slides

Dying Well: Medical Ethics at the End of Life

Dying Well: Medical Ethics at the End of Life. James L. Bernat, M.D. Professor of Medicine (Neurology) Dartmouth Medical School. Overview. Dying in America Life-ending acts: Refusal of life-sustaining therapy Physician-assisted suicide Euthanasia Refusal of hydration and nutrition

538 views • 31 slides

Anuj Arora Email: anuja@uci.edu

Anuj Arora Email: anuja@uci.edu. History of Inventors. George Stibitz 1904-1995. Pioneer of digital computing and remote job entry. History Leading to an Idea.

254 views • 11 slides

Suddenly Sick

Suddenly Sick. http ://seattletimes.nwsource.com/news/health/suddenlysick/suddenlysick.pdf. Conflict of Interest by Guideline Writers. Change a number, create a patient.

185 views • 8 slides

Creating or Enhancing Ethics Programs Session

Creating or Enhancing Ethics Programs Session. General reactions or questions to the presentation Do you have an ethics program? How effective is the program? If not, what do think about initiating an ethics program?. Summary. Take home points

156 views • 2 slides

Sample Introduction: Colleagues Why Talk About End of Life Care?

Sample Introduction: Colleagues Why Talk About End of Life Care?. DID YOU KNOW...? 73% of Americans would prefer to die at home, but anywhere between 20-50% of Americans die in hospital settings.

125 views • 1 slides

The Institute for Molecular Diversity & Drug Design (IMD 3 ) 14th Annual Symposium Molecular Targets for Drugs &amp

173 views • 1 slides